Assignee
SEARLE LLC
US18 patents
Top patents by PatentIndex Score
US6458851B1Oct 1, 2002
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
SEARLE LLC35 citations92
US7226932B2Jun 5, 2007
Self-emulsifying drug delivery system
SEARLE LLC28 citations89
US6586434B2Jul 1, 2003
Method for the preparation of tetrahydrobenzothiepines
SEARLE LLC16 citations89
US6740663B2May 25, 2004
Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
SEARLE LLC24 citations88
US7012094B1Mar 14, 2006
Substituted furans and furanones for the treatment of inflammation
SEARLE LLC11 citations84
US7320983B2Jan 22, 2008
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE LLC8 citations82
US7829564B2Nov 9, 2010
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE LLC4 citations74
US7531538B2May 12, 2009
α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE LLC6 citations74
US6489366B1Dec 3, 2002
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
SEARLE LLC6 citations73
US7157101B2Jan 2, 2007
Micronized eplerenone compositions
SEARLE LLC3 citations72
USRE42889ENov 1, 2011
α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE LLC2 citations63
US7339078B2Mar 4, 2008
Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
SEARLE LLC6 citations63
US6569905B1May 27, 2003
Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
SEARLE LLC4 citations62
US6458850B1Oct 1, 2002
Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
SEARLE LLC6 citations62
US7022672B2Apr 4, 2006
Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor
SEARLE LLC1 citations58
US7297793B2Nov 20, 2007
Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
SEARLE LLC0 citations52
US6890958B2May 10, 2005
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
SEARLE LLC1 citations52
US6638969B1Oct 28, 2003
Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
SEARLE LLC1 citations51